Abstract:Purpose: Boron neutron capture therapy (BNCT) is an emerging binary radiotherapy, which is limited for application due to the challenge of targeted delivery into tumor nowadays. Here, we propose the use of iRGD-modified polymeric nanoparticles for active targeted delivery of boron and doxorubicin (DOX) in BNCT. Methods: 10B-enriched BSH was covalently grafted to PEG-PCCL to prepare 10B-polymer, then surface-modified with iRGD. And, DOX was physically incorporated into polymers afterwards. Characterization of prepared polymers and in vitro release profile of DOX from polymers were determined by several methods. Cellular uptake of DOX was observed by confocal microscope. Accumulation of boron in cells and tissues was analyzed by ICP-MS. Biodistribution of DOX was studied by ex vivo fluorescence imaging and quantitative measurement. Tumor vascular normalization of Endostar for promoting delivery efficiency of boron on refractory B16F10 tumor was also studied. Results: The polymers were monodisperse and spheroidal in water with an average diameter of 24.97 nm, which were relatively stable at physiological pH and showed a sustained release of DOX, especially at endolysosomal pH. Enhanced cellular delivery of DOX was found in iRGD-modified polymer group. Cellular boron uptake of iRGD-modified polymers in A549 cells was remarkably raised fivefold (209.83 ng 10B/106 cells) compared with BSH. The polymers represented prolonged blood circulation, enhanced tumor accumulation of 10B against BSH, and favorable tumor:normal tissue boron concentration ratios (tumor:blood = 14.11, tumor:muscle = 19.49) in A549 tumor-bearing mice 24 hrs after injection. Both fluorescence imaging and quantitative measurement showed the highest tumor accumulation of DOX at 24 hrs after injecting of iRGD-modified polymers. Improvement of vascular integrity and reduction of vascular mimicries were found after Endostar injection, and raised tumor accumulation of boron as well. Conclusion: The developed nanoparticle is an inspiring candidate for the safe clinical application for BNCT.

Doxorubicin-Loaded Boron-Rich Polymer Nanoparticles for Orthotopically Implanted Liver Tumor Treatment

One-pot Synthesis of Hollow PDA@DOX Nanoparticles for Ultrasound Imaging and Chemo-Thermal Therapy in Breast Cancer

Doxorubicin-Loaded Carborane-Conjugated Polymeric Nanoparticles As Delivery System for Combination Cancer Therapy

Biotin-Conjugated Multilayer Poly [D,l-Lactide-co-glycolide]-lecithin-polyethylene Glycol Nanoparticles for Targeted Delivery of Doxorubicin.

Enhanced in Vivo Antitumor Efficacy of Doxorubicin Encapsulated Within Laponite Nanodisks.

Doxorubicin Delivery to 3d Multicellular Spheroids and Tumors Based on Boronic Acid-Rich Chitosan Nanoparticles

Remarkable Boron Delivery Of iRGD-Modified Polymeric Nanoparticles For Boron Neutron Capture Therapy

pH-sensitive doxorubicin-loaded polymeric nanocomplex based on β-cyclodextrin for liver cancer-targeted therapy.

Preparation of DOX/BSANP and Its Antitumor Effect on Bel-7404 Liver Cancer Cells in Vitro and in Vivo

Enhanced Antitumor Efficacy of Doxorubicin-Encapsulated Halloysite Nanotubes.

Doxorubicin-loaded star-shaped copolymer PLGA-vitamin E TPGS nanoparticles for lung cancer therapy

Doxorubicin-loaded Glycyrrhetinic Acid-Modified Alginate Nanoparticles for Liver Tumor Chemotherapy.

A tumor environment responsive doxorubicin-loaded nanoparticle for targeted cancer therapy.

Enhanced Tumor Delivery and Antitumor Response of Doxorubicin-Loaded Albumin Nanoparticles Formulated Based on a Schiff Base.

Designed preparation of polyacrylic acid/calcium carbonate nanoparticles with high doxorubicin payload for liver cancer chemotherapy

Hypoxia-Responsive Polypeptide Nanoparticles Loaded with Doxorubicin for Breast Cancer Therapy

Efficient Delivery of Dox to Nuclei of Hepatic Carcinoma Cells in the Subcutaneous Tumor Model Using Ph-Sensitive Pullulan-Dox Conjugates

The enhanced chemotherapeutic effects of doxorubicin loaded PEG coated TiO2 nanocarriers in an orthotopic breast tumor bearing mouse model

Study on the Application of Doxorubicin-Loaded Magnetic Nanodrugs in Targeted Therapy of Liver Cancer

Nano-Rods of Doxorubicin with Poly(L-Glutamic Acid) As A Carrier-Free Formulation for Intratumoral Cancer Treatment

Smart doxorubicin nanoparticles with high drug payload for enhanced chemotherapy against drug resistance and cancer diagnosis